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E-mail address: a.r.lehmann@sussex.ac.ukThe cell uses specialised Y-family DNA polymerases or damage avoidance mechanisms to replicate
past damaged sites in DNA. These processes are under complex regulatory systems, which employ
different types of post-translational modiﬁcation. All the Y-family polymerases have ubiquitin bind-
ing domains that bind to mono-ubiquitinated PCNA to effect the switching from replicative to Y-
family polymerase. Ubiquitination and de-ubiquitination of PCNA are tightly regulated. There is also
evidence for another as yet unidentiﬁed ubiquitinated protein being involved in recruitment of Y-
family polymerases to chromatin. Poly-ubiquitination of PCNA stimulates damage avoidance, and,
at least in yeast, PCNA is SUMOylated to prevent unwanted recombination events at the replication
fork. The Y-family polymerases themselves can be ubiquitinated and, in the case of DNA polymerase
g, this results in the polymerase being excluded from chromatin.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The ways in which cells are able to replicate past damage in
DNA has been the subject of intensive research over the last
12 years, since the discovery of the central role of the Y-family of
DNA polymerases. The topic has been extensively reviewed (e.g.
[1–3]). Recent studies have highlighted the crucial role of post-
translational modiﬁcations in the recruitment and regulation of
these polymerases.
2. RAD6 epistasis group
Work on the yeast Saccharomyces cerevisiae in the 1960s and
1970s identiﬁed many mutant strains that were sensitive to DNA
damaging agents. Epistasis analysis resulted in these mutants
being assigned to three different epistasis groups: the RAD3 group,
which is involved in nucleotide excision repair; the RAD52 group
involved in recombination repair and the RAD6 group with miscel-
laneous functions including the replication of damaged DNA,
sometimes referred to as postreplication repair (PRR). RAD6 is a
central player in this group. rad6 mutants are sensitive to many
DNA-damaging agents and importantly are hypomutable by many
of these agents. A seminal paper in 1987 by Jentsch et al. identiﬁed
the Rad6 protein as an E2 ubiquitin conjugating enzyme, implicat-
ing ubiquitination in the PRR process [4]. rad18 mutants have UV
sensitivity phenotypes similar to those of rad6. Rad18 protein
binds to single-stranded DNA and has a RING ﬁnger close to itscal Societies. Published by ElsevierN-terminus, suggesting that it is an E3 ubiquitin ligase [5]. Further-
more Rad18 and Rad6 interact strongly to form a heterodimeric
complex [5]. Two other genes, UBC13 and MMS2, are epistatic to
RAD6 and RAD18 but mutants in these genes are less sensitive to
DNA damage and are not hypomutable. They also form a heterodi-
meric complex, which has E2 ubiquitin-conjugating activity and
forms ubiquitin chains linked at lys-63, rather than the lys-48 link-
age that signals target proteins for proteasomal degradation. Final-
ly Rad5 is another RING ﬁnger protein in this epistasis group,
which can interact with Ubc13 and Rad18 as well as forming
homodimers [6]. The hypothesis that developed from these epista-
sis studies was that Rad6 and Rad18 controlled all postreplication
repair pathways. These included an error-free pathway involving
Ubc13–Mms2 and Rad5 and an error-prone pathway [7] (see arti-
cle by W. Xiao in this volume).
For about three decades, accepted dogma was that the high
stringency of the replicative polymerases, which, under normal
conditions are blocked by most types of DNA damage, was some-
how lowered to enable them to bypass DNA damage. This hypoth-
esis was found to be wrong in 1999 with the discovery of a new
(now called Y) family of DNA polymerases, which have a more
open structure than replicative polymerases. This enables them
to accommodate damaged bases in their active sites and enables
them to synthesise DNA past damaged bases [8]. It is this transle-
sion synthesis (TLS) that, with some notable exceptions, is error-
prone and results in the generation of mutations during DNA rep-
lication. In S. cerevisiae there are three polymerases implicated in
PRR. Y-family DNA polymerase (pol)g carries out TLS past UV-in-
duced cyclobutane pyrimidine dimers, in most cases inserting
the correct bases opposite the lesions [9]. TLS polymerase pastB.V. Open access under CC BY-NC-ND license.
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subunit Rev3, actually a member of the B-family, and a regulatory
subunit Rev7, together with Y-family Rev1. polf and Rev1 are abso-
lutely required for mutagenesis induced by most types of DNA
damage.Fig. 1. Regulation of PCNA mono-ubiquitination in human cells. Blockage of the
replicative DNA polymerases at the replication fork exposes single-stranded DNA,
which becomes coated with RPA. Rad18 and Rad6 are recruited and activated to
stimulate the ubiquitination of PCNA. This is stimulated by PTIP and claspin/Chk1.
De-ubiquitination of mono-ubiquitinated PCNA is effected by USP1/UAF1, which is
stimulated by Elg1. USP1 undergoes cycles of synthesis and autocleavage and the
synthesis of its mRNA is inhibited by UV.3. Ubiquitination of PCNA
What then is the connection between the Y-family polymer-
ases and the ubiquitination systems described in the previous
paragraph? The answer to this conundrum came with another
seminal paper from the Jentsch group, in which the target of
these ubiquitination complexes was identiﬁed as PCNA, the
homotrimeric sliding clamp accessory protein, required for repli-
cation by eukaryotic DNA polymerases [10]. Hoege et al showed
that PCNA is mono-ubiquitinated on lysine-164 by Rad6 and
Rad18. The mono-ubiquitinated PCNA serves as a substrate for
further extension by Ubc13–Mms2 and Rad5 to generate poly-
ubiquitinated PCNA with the chains linked via lysine-63 in ubiq-
uitin [10,11]. To explain the phenotypes of the corresponding
mutants, the authors proposed that mono-ubiquitination of
PCNA brought about TLS by Y-family polymerases, this being
the postulated Rad6–Rad18-dependent error-prone process,
whereas poly-ubiquitination channelled lesions into a different,
error-free, process. Further genetic studies by Stelter and Ulrich
largely substantiated this hypothesis [12]. Ubiquitination of
PCNA was required for TLS by polg, for mutagenic TLS by polf
and Rev1 and for Ubc13–Mms2–Rad5 mediated error-free path-
ways. In elegant subsequent studies, both these groups showed
that ubiquitination of PCNA and/or TLS could be delayed until
the G2 phase of the cell cycle, when replication had been largely
completed, without any deleterious effect on the cell [13,14].
These ﬁndings demonstrated that gaps are left opposite lesions
during S phase and ﬁlling of these gaps by TLS can occur behind
the replication fork, as also suggested by earlier studies [15–18].
Using UV-irradiated chicken DT40 cells, Edmunds et al. showed
that ubiquitination of PCNA was required for gap-ﬁlling behind
the replication fork. In contrast, replication past a lesion could
also occur at the replication fork. This was dependent on Rev1
but independent of ubiquitinated PCNA [19]. See article by H. Ul-
rich in this issue for further discussion.
Using an ingenious trick of splitting PCNA into an N-terminal
fragment of aa1–163 and a ubiquitinated C-terminal fragment of
aa164–258 in which the ubiquitin was attached to the N-terminal
amino group of aa164, Washington and co-workers were able to
produce sufﬁcient ‘‘ubiquitinated PCNA’’ from these fragments to
determine its crystal structure. They showed that the protein
reconstituted from these two fragments formed a ring that was
superimposable with intact PCNA. It was biologically active
in vivo and in vitro and was therefore an accurate mimic of PCNA
ubiquitinated at lysine 164. In the crystal structure, the ubiquitin
moiety was located on the back surface of the PCNA [20], whereas
DNA polymerases interact with PCNA on the front face.4. Ub trigger
The TLS polymerases, the ubiquitination systems and lysine 164
of PCNA are all conserved throughout eukaryotes, suggesting a
similar system of regulation in other organisms. PCNA mono-ubiq-
uitination in response to DNA damage has been detected in Schizo-
saccharomyces pombe [21,22], Xenopus laevis [23], and human cells
[24,25]. In all these systems, if ubiquitination of PCNA is prevented
by mutating lysine 164 of PCNA, the cells are sensitised to killing
by UV and other DNA damaging agents [10,21,26], highlighting
the biological importance of PCNA ubiquitination.Ubiquitination of PCNA is triggered in human cells, S. pombe and
S. cerevisiae in response to UV, various chemical mutagens and to
depletion of nucleotides by hydroxyurea (HU) [21,24,26,27]. It is
not however stimulated by agents that generate double-strand
breaks as the major lesion. The trigger for PCNA ubiquitination is
thought to be single-stranded DNA exposed at the replication fork
by dissociation of the replicative helicase from the polymerase
stalled at the lesion [28]. In vitro studies have shown that ssDNA
coated with RPA stimulates the recruitment and E3 ligase activity
of Rad18 [27]. This has led to a widely accepted model in which
single-stranded DNA exposed at the replication fork gets coated
with RPA. This leads to the recruitment of Rad18, which in turn
binds Rad6 and leads to the ubiquitination of PCNA (see Fig. 1).
5. Ub regulators/USP1
This simple, but elegant model, could pleasingly account for
most of the phenomena associated with PCNA ubiquitination.
However further experimentation has revealed unexpected com-
plexities. In human cells, PCNA ubiquitination levels are inﬂuenced
by PTIP [29], the tumour suppressors p53 and p21 [30,31], by cla-
spin and chk1[32] and by the chromatin remodellers, Ino80 in
yeast [33] and by Rsc2 in yeast and its orthologue Baf180 in human
cells (A. Niimi, J.A. Downs and ARL, unpublished observations).
Stimulation of PCNA ubiquitination by Chk1-claspin was not
dependent on Chk1 kinase activity, but rather seems to be medi-
ated by an interaction between claspin and PCNA, which results
in increased chromatin-bound Rad18 [32].
Although Rad6–Rad18 provides the major pathway for ubiquiti-
nation of PCNA, there is evidence for other minor pathways in S.
cerevisiae, chicken DT40 cells and in human cells under certain
conditions, in which residual ubiquitination has been observed in
the absence of Rad6 or Rad18 [34–36]. In S. cerevisiae rad6mutants,
this minor pathway could be detected in undamaged cells or in
cells treated with methyl methanesulphonate (MMS). It was
dependent on the Ask1 protein, the main subunit of the replication
coupling assembly factor [36]. With human systems, evidence has
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CRL4Cdt2 [37] or by Rnf8 [38] as well as by Rad18. In undamaged
cells, depletion of CRL4Cdt2 resulted in reduced Ub-PCNA in undam-
aged cells and in some cell lines CRL4Cdt2 could contribute to dam-
age-induced ubiquitination [37]. Likewise in A549 cells depleted of
RNF8, there was a substantial reduction in ubiquitination of PCNA
following UV or N-methyl-N0-nitro-N-nitrosoguanidine treatment
[38].
The de-ubiquitination of Ub-PCNA in human cells is carried out
by the de-ubiquitinating enzyme USP1 [39]. The enzymes with a
similar function in the yeasts have not yet been identiﬁed. USP1
keeps the level of ubiquitinated PCNA at a low level in undamaged
cells. High doses of UV irradiation result in the disappearance of
USP1 from the cells. USP1 is subject to an autocleavage reaction,
which regulates its cellular concentration [39]. It is stabilized and
activated in the cell by its partner protein UAF1. UV-irradiation re-
sults in decreased transcription of the USP1 gene, so that the autoc-
leavage results in its disappearance from the cell [40]. This loss of
USP1 is not however seen after hydroxyurea, MMS or mitomycin C
treatment [26,40], suggesting that it is not essential for the up-reg-
ulation of PCNA ubiquitination. Elg1, a protein related to RFC1, the
large subunit of Replication Factor C, also interacts with USP1 and
UAF1. Depletion of Elg1 resulted in increased levels of mono-ubiq-
uitinated PCNA in undamaged cells and conversely over-expres-
sion of Elg1 stabilised USP1 and reduced the level of UV-induced
Ub-PCNA [41]. The data in this work suggest that the interaction
of Elg1 with USP1–UAF1 down-regulates PCNA mono-ubiquitina-
tion (see article by K.J. Myung in this issue for further discussion).
Although activation of the ATR-mediated checkpoint and PCNA
ubiquitination are both triggered by the exposure of single-
stranded DNA close to the replication fork, the two processes ap-
pear, in several organisms, to be largely independent of each other
[21,26–29,32]. The regulation of PCNA ubiquitination is summa-
rised in Fig. 1.
6. UBZ/UBM motifs
The experiments of Hoege et al. [10] and Stelter and Ulrich [12]
suggested that the function of PCNA mono-ubiquitination was to
channel stalled replication forks into the TLS pathways, a concept
now termed the polymerase switch. In human cells, there are four
Y-family DNA polymerases, polg, poli, polj and Rev1 as well as
polf that are responsible for TLS. Pols g, i and j all have PIP-box
PCNA binding motifs and have been shown to interact with PCNA
using yeast-2-hybrid analysis [42–44]. Using human cell extracts,
the groups of Lehmann and Yamaizumi demonstrated that ubiqui-
tination of PCNA increased its afﬁnity for polg, immediately pro-
viding an attractive mechanism for mediating the polymerase
switch [24,25]. This was followed by the demonstration that all
four Y-family polymerases have novel ubiquitin-binding motifs
[45–48], which were responsible for their increased afﬁnity for
ubiquitinated PCNA (see also [49]). In the case of polg and polj,
these are zinc ﬁnger motifs designated UBZ (polg has one, whereas
polj has two), whereas for poli and Rev1, the ubiquitin-binding
motifs are designated UBMs, of which there are two in both pro-
teins. NMR structures of the UBZ from polg and the UBM of poli
have been solved [50–52].
Several studies have conﬁrmed the biological importance of
these ubiquitin-binding motifs. Deletion of the UBZ or mutation
of an invariant aspartate residue substantially reduced the ability
of human polg to accumulate in replication foci in human cells
and resulted in increased UV sensitivity compared to wild-type
polg [45,53,54]. Likewise mutation of invariant LP residues in
the UBM of poli [45] and Rev1 [47] prevented their concentration
in replication factories. In S. cerevisiaemutation of the UBZ motif of
polg resulted in increased sensitivity to both killing and mutagen-esis by UV light [49,55] and to mutagenesis by 8-oxoguanine [56].
In Rev1, mutation of the ﬁrst UBM, UBM1, had no effect, whereas
mutation of the second, UBM2, resulted in decreased UV survival
and increased UV mutagenesis [57–59].
7. In vitro studies
Attempts have been made to ubiquitinate PCNA in cell free ex-
tracts or with reconstituted recombinant proteins and to examine
its effect on polymerase switching. Using recombinant yeast Rad6
and Rad18, Garg and Burgers succeeded in generating ubiquitinat-
ed PCNA. The ubiquitination reaction was dependent on PCNA
being loaded onto primed M13 DNA by RFC [60,61] and in a similar
system using human proteins, appeared to be stimulated by inter-
action of PCNA with either pold or RFC [61]. The ubiquitination had
no effect on polymerisation by pold, but stimulated the ability of
polg and Rev1 to bypass an AP site in the M13 template [60]. In
keeping with the in vivo studies described above, the stimulation
of the bypass activity of Rev1 and its interaction with ubiquitinated
PCNA was dependent on the second (UBM2) but not the ﬁrst
(UBM1) UBM motif.
Zhuang et al. blocked progress of replication by pold by supply-
ing the enzyme with just two dNTPs. Under these blocked condi-
tions, there was a limited exchange of pold with polg in the
presence of PCNA, but a dramatically increased exchange if PCNA
was substituted with the mono-ubiquitinated form. This polymer-
ase switch was dependent on the C-terminal region containing
both PIP box and UBZ domains [62]. In a system using human pro-
teins, two mechanisms for switching from pold to polg were de-
tected, one dependent on and one independent of ubiquitinated
PCNA. The PCNA-dependent mechanism required that the UBZ mo-
tif of polg was intact [61].
Curiously, when fractionated HeLa cell extracts supplemented
with PCNA that was either wild-type or mutated at K164, were
used to replicate a plasmid containing a single cyclobutane pyrim-
idine dimer at a deﬁned site, replication past the lesion by polg ap-
peared not to require ubiquitinated PCNA [63].
8. Another ubiquitinated protein?
There is no doubt that interaction of Y-family polymerases with
ubiquitinated PCNA is a crucial step in mediating efﬁcient TLS. Re-
cent evidence suggests however that there is likely to be another
important ubiquitinated protein involved in recruiting polymer-
ases to chromatin in replication factories. Firstly polg, poli and
Rev1 are localised in replication factories during normal S phase
in unperturbed cells, when the level of ubiquitinated PCNA is very
low [64,65]. Secondly, we found that ubiquitination of PCNA after
UV treatment is abolished if cells are incubated with proteasome
inhibitors. Nevertheless polg accumulates normally into replica-
tion factories under these conditions [66]. Third, we have found
that following DNA damage, polg becomes phosphorylated by
ATR. This phosphorylation takes place exclusively in chromatin
and is important for efﬁcient TLS. It is dependent on the UBZ motif
but not on binding to PCNA [67]. Fourth, using whole cell extracts
from human ﬁbroblasts, Schmutz et al. observed that PCNA be-
came ubiquitinated by Rad18 when the replication fork was stalled
in a primed ssDNA replication assay [68]. Using this system, repli-
cation past a CPD was dependent on polg and required both its PIP
and UBZ motifs, but it did not require ubiquitination of PCNA [69].
A recent model that we have proposed for regulation of polg,
based on these ﬁndings, is presented in Fig. 2. We envisage that
for accumulation of polg in chromatin in replication factories,
the UBZ needs to bind to an unidentiﬁed ubiquitinated protein (X
in Fig. 2), perhaps ubiquitinated histone (Step 2). DNA damage trig-
gers phosphorylation of chromatin-bound polg by ATR (Step 3).
Fig. 2. Models for regulation of Polg. (1) Polg in the nucleoplasm becomes ubiquitinated and an intramolecular interaction with the UBZ and PIR motifs results in these
motifs being unavailable for interaction with other nuclear proteins and polg is excluded from chromatin. Ubiquitinated polg disappears from the cell after UV-irradiation.
(2) In S phase cells, polg is recruited to replication factories by interaction with a hypothetical ubiquitinated protein X, possibly a ubiquitinated histone. (3) In response to
damage, ATR phosphorylates polg, and this stimulates transfer of polg either directly onto ubiquitinated PCNA at a stalled fork (4A) or indirectly via binding of another
hypothetical protein Y to the phosphorylated site (4B, 5).
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another protein (Steps 4B and 5) triggers the hand-off of polg onto
ubiquitinated PCNA at the stalled replication fork [67].
9. Poly-ubiquitination of PCNA
Hoege et al. clearly demonstrated that PCNA became poly-ubiq-
uitinated in response to DNA damage in S. cerevisiae [10]. The poly-
ubiquitination step mediated by Rad5 and Ubc13–Mms2 is depen-
dent on previous mono-ubiquitination [11]. PCNA poly-ubiquitina-
tion is also readily demonstrated in S. pombe [21] and in Xenopus
extracts [23,29]. In contrast poly-ubiquitination has been much
more difﬁcult to detect in mammalian systems [24], even though
Ubc13, Mms2 and Rad5 are all conserved in eukaryotes. Three
groups have succeeded in detecting poly-ubiquitination in re-
sponse to different damaging agents in human cells, albeit at a
much lower level than in the yeasts [70–73]. Poly-ubiquitinated
PCNA was more evident after MMS treatment than after UV-irradi-
ation [71,74]. Di-ubiquitination has been observed in replicating
xenopus extracts treated with aphidicolin [28]. Genetic studies
have shown that a ubiquitin-lysine-63 linked protein protects hu-
man cells from mutagenesis by UV, cisplatin and polycyclic hydro-
carbons. Transfection of cells with ubiquitin-K63R, which cannot
form K63-linked poly-ubiquitin chains and was assumed to inhibit
the formation of such chains in the transfected cells, resulted in a
modest sensitisation of cells to cisplatin, but not to UV or benzo[a]-
pyrene diolepoxide. However there was a substantial effect onmutagenesis induced by all three agents, especially the benzo[a]-
pyrene diolepoxide [70,75]. By analogy with the yeast studies,
we can assume that these effects were mediated by poly-ubiquiti-
nation of PCNA.
There are two human orthologues of Rad5, namely SHPRH and
HLTF [71,72,74,76]. These E3 ligases interact with each other and
with Rad18, PCNA and Ubc13. Co-expression of both proteins
greatly increased the level of poly-ubiquitination of PCNA. Deple-
tion of either SHPRH or HLTF using shRNA resulted in reduced lev-
els of MMS-induced PCNA poly-ubiquitination, sensitisation of
HCT116 cells to MMS and increased chromosome breakage
[71,74]. However, in embryonic ﬁbroblasts from mice deleted for
both genes, PCNA poly-ubiquitination was reduced substantially,
but some residual poly-ubiquitination remained, suggesting a third
E3 ubiquitin ligase that can carry out PCNA poly-ubiquitination.
Furthermore, at variance with the human cell shRNA results, B cells
from these mice showed no detectable sensitivity to UV, cisplatin
or MMS [77].
Another recent study has highlighted the complexity and dam-
age speciﬁcity of the roles of SHPRH and HLTF in human cells [78].
Depletion of HLTF resulted in increased susceptibility of a plasmid-
borne supF gene to UV mutagenesis, whereas depletion of SHPRH
had no effect. The converse was true for MMS treatment, which re-
sulted in enhanced mutagenesis on depletion of SHPRH but not
HLTF. Biochemical experiments showed that MMS treatment of
293 cells, resulted in HLTF being degraded by the proteasome
and a consequent stronger interaction between SHPRH and
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Poly-ubiquitination of PCNA was not detected in this study, but
intriguingly HLTF appeared to stimulate polg accumulation in rep-
lication factories and mono-ubiquitination of PCNA, the latter
being dependent on an intact RING ﬁnger in HLTF. Depletion of
HLTF by siRNA resulted in a reduction in mono-ubiquitination of
PCNA in untreated cells as well as in cells treated with aphidicolin
or UV-irradiation. In contrast, there was no obvious difference in
PCNA mono-ubiquitination between wild-type and htlf/shprh/
 MEFs after UV-irradiation in the study of Lin et al. [78]. Finally
SHPRH was shown to interact with both polg and polj and this
interaction was increased following MMS treatment of the cells.
This work demonstrates an important regulatory role for these
two homologues of Rad5 in the responses of cells to DNA damage,
but further work is obviously needed to gain insight into which if
any of these roles requires mono- or poly-ubiquitination of PCNA.
There is as yet, little understanding of the error-free process
that is dependent on poly-ubiquitination of PCNA. Using a plasmid
containing two closely spaced pyrimidine (6-4) pyrimidone photo-
products on opposite strands of the DNA, Zhang and Lawrence
showed that of the plasmids replicated in S. cerevisiae, 50% used
a recombination mechanism, and 50% of these recombination
events were dependent on Rad18 and Rad5 suggesting that the
pathway might be dependent on PCNA poly-ubiquitination [79].
However using a S. pombe plasmid replication assay system that
distinguishes between TLS and recombination mechanisms when
replicating past a single site-speciﬁc cyclobutane pyrimidine di-
mer, Coulon et al. found, unexpectedly, that most TLS events were
dependent on Mms2, Ubc13 and Rad8 (the S. pombe orthologue of
Rad5) [80]. This is consistent with the ﬁndings discussed above
that one of the human Rad5 homologues affects mono-ubiquitina-
tion of PCNA and correct localisation of polg.
Branzei, et al. have developed a system for analyzing template
switching mechanisms in S. cerevisiae cells treated with MMS. X-
shaped recombination intermediates, possibly hemicatenane
structures, are detected using two-dimensional gel electrophoresis.
Genetic dissection of the requirements for forming these X-struc-
tures showed that they are promoted by both poly-ubiquitination
and SUMOylation of PCNA [81] (see article by Branzei in this issue
for further discussion). Apart from its RING ﬁnger conferring ubiq-
uitin ligase activity, Rad5 and its mammalian homologues have
DNA-dependent ATPase activity, which is important for the re-
sponse to DNA damage. Evidence and models for how this might
be involved in processing stalled forks or gaps behind the forks
have been provided by Haracska and co-workers [82,83].
10. Ubiquitination of Y-family polymerases
A fraction of polg and poli in human cells is itself mono-ubiq-
uitinated and this ubiquitination is dependent on an intact UBZ or
UBM, respectively [45]. Similar ﬁndings were reported for Rev1
and polj [47,48]. Further studies suggested that binding of ubiqui-
tin to the UBZ or UBM could result in an intramolecular transfer of
the ubiquitin onto the polymerase target without the need for an
E3 ubiquitin ligase [84,85]. A detailed study of the ubiquitination
of human polg showed that the principal site of ubiquitination
was lysine-682 in the bipartite nuclear localisation signal (NLS)
adjacent to the PIP box motif at the C-terminus of the protein. If
this lysine was unavailable, one of three other lysines in the NLS
or PIP box motif was ubiquitinated. It is likely that ubiquitination
of polg results in an intramolecular interaction between the UBZ
and the ubiquitinated lysine on the same molecule. The effect of
this is to make the UBZ and PCNA-interacting region (PIR, encom-
passing the PIP box and NLS) unavailable for interaction with ubiq-
uitinated PCNA (Fig. 2, Step 1). The ubiquitinated polg was
excluded from the chromatin and from the replication factories,and it was postulated that this might be a regulatory mechanism
to keep polg away from sites of replication in the absence of dam-
age. This was supported by the ﬁnding that the ubiquitinated form
of polg disappeared following DNA damage, making the polg once
again available for interaction with ubiquitinated PCNA [53]. This
work provides an interesting example of how the process of
mono-ubiquitination can either positively or negatively regulate
the assembly of TLS-competent protein complexes, depending on
which substrates are modiﬁed by ubiquitin. Whereas ubiquitina-
tion of PCNA favours its interaction with polg, ubiquitination of
polg hinders this interaction, keeping polg away from replication
forks.11. SUMOylation of PCNA
The most marked modiﬁcation of PCNA in S. cerevisiae is
SUMOylation, which takes place during an unperturbed S phase
[10]. It is increased following treatment with high doses of DNA
damaging agents but not by moderate doses [10]. PCNA is SUMOy-
lated either on lysine 164, the same residue that is ubiquitinated in
response to DNA damage, or on lysine 127. SUMOylation increases
the afﬁnity of PCNA for the anti-recombinogenic Srs2 protein
[86,87], which displaces Rad51 from DNA. The interaction between
SUMOylated PCNA and Srs2 is mediated by the C-terminal 138 res-
idues of Srs2. These results, together with epistasis analyses, led to
a model in which sumoylation of PCNA prevents unwanted recom-
bination during DNA replication. It has also been suggested that
SUMOylation on lysine 164 prevents unwarranted ubiquitination
at this site, which might result in recruitment of error-prone poly-
merases during replication in unperturbed cells [88].
As with ubiquitination, SUMOylation of PCNA is dependent on
its being loaded onto DNA [89]. Using the same trick of splitting
the molecule into two parts that they used for solving the crystal
structure of ubiquitinated PCNA, Washington and co-workers also
solved the structure of SUMOylated PCNA [90]. As with the ubiqui-
tin moiety, they found that the SUMO was located on the back face
of PCNA but in a different position from the ubiquitin. The authors
proposed that proteins interacting with the modiﬁers (e.g. Y-poly-
merases or Srs2) can be held ‘‘in reserve’’ on the back face until
they are either employed at the front face or dissociate from the
modiﬁed PCNA.
Although SUMOylation of PCNA clearly plays an important role
in S. cerevisiae, its role in other organisms is much less clear. It has
been detected in Xenopus extracts during DNA replication [23] and
after treatment with UV or aphidicolin [29], but it has not so far
been detected in S. pombe [21] or human cells. Furthermore,
although human and Caenorhabditis elegans RTEL1 fulﬁl equivalent
functional roles to Srs2, there are no structural homologues of Srs2
in animal cells. Moreover, even though there is an Srs2 orthologue
in S. pombe, the C-terminal tail that interacts with SUMOylated
PCNA in S. cerevisiae [87] is not conserved in S. pombe. This raises
the question of whether this particular modiﬁcation of PCNA is
conﬁned to organisms (or organs) with a naturally high rate of
recombination that needs to be kept in check during DNA
replication.12. SUMOylation of polg
Early embryos of C. elegans are resistant to high levels of DNA
damage and this resistance is dependent on POL-g and the SUMO
E3 ligase GEI-17 [91]. In embryos depleted of gei-17, POL-g was
degraded following exposure to DNA damage. This degradation
was mediated by the Cul4, DDb1, Cdt2 pathway. Polg was pro-
tected from degradation by GEI-17 mediated sumoylation of POL-
g on lysines 85 and 260. Thus, in C. elegans, SUMOylation of
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are conserved in human polg, we have not found any effect of
mutating these residues on the stability of polg following DNA
damage in human cells. Nor have we detected a SUMOylated form
of human polg (T. Goehler and ARL, unpublished observations). It
would be interesting to see if SUMOylation of polg could be de-
tected in other organisms.
13. Discussion
Our understanding of the role of ubiquitination and SUMOyla-
tion reactions has increased dramatically over the last 10 years.
The attractive and apparently simple model of mono-ubiquitina-
tion of PCNA mediating a switch to TLS by Y-family polymerases
and poly-ubiquitination mediating an error-free template switch-
ing mechanism has stood the test of time, but in 2011 the reality
appears to be not so simple and many questions remain to be
addressed.
Mono-ubiquitination of PCNA appears to be under complex reg-
ulation with many proteins other than Rad6 and Rad18 affecting
and regulating both ubiquitination, as well as de-ubiquitination
by USP1 (summarised in Fig. 1). We have currently little idea what
these regulatory proteins are doing, or of the signiﬁcance of the
mono-ubiquitination that appears to be independent of Rad18.
Poly-ubiquitination of PCNA remains an almost complete mystery.
Although it is easily detectable in S. cerevisiae and especially in S.
pombe, it is barely detectable in mammalian systems unless the
relevant players are overexpressed. To add to the complexity, pro-
teins presumed by extrapolation from the yeast data to be involved
in poly-ubiquitination, appear from recent publications to have
other roles as well, including in mono-ubiquitination of PCNA.
Although genetic studies in yeast have provided evidence for a role
for poly-ubiquitination in a template-switch mechanism, there
have been no biochemical studies to indicate how poly-ubiquiti-
nated PCNA might stimulate this process. Likewise PCNA SUMOy-
lation clearly suppresses replication-associated recombination in
yeasts, but does it have an important function in other organisms?
With regards to the Y-family polymerases, the ubiquitin-bind-
ing motifs are clearly important for binding to ubiquitinated PCNA
at stalled forks, but I have listed evidence suggesting that at least in
the case of polg, binding of the UBZ to another as yet unidentiﬁed
protein is required for it to fulﬁl its role efﬁciently. This may well
be the case for the other Y-family polymerases as well. Finally
there is strong biochemical evidence for the ubiquitination of the
Y-family polymerases themselves and this appears to keep polg
away from replication forks. As yet however biological evidence
for the importance of this function is lacking, and there are no data
suggesting a function for ubiquitination of the other polymerases.
It is to be hoped that the next decade will be as fruitful as the last
one in helping to unravel some of these mysteries and to improve
our understanding of how cells replicate damaged DNA.
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